Frontier Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.8M Buy
505,628
+130,297
+35% +$9.07M 0.33% 120
2025
Q4
$24.9M Sell
375,331
-313,363
-46% -$20.3M 0.26% 141
2025
Q3
$46.3M Sell
688,694
-243,677
-26% -$19.3M 0.42% 81
2025
Q2
$81.4M Sell
932,371
-35,907
-4% -$2.81M 0.75% 22
2025
Q1
$66.1M Buy
968,278
+275,064
+40% +$22.4M 0.72% 34
2024
Q4
$53.9M Sell
693,214
-42,712
-6% -$3.16M 0.51% 65
2024
Q3
$49.3M Sell
735,926
-7,111
-1% -$584K 0.46% 77
2024
Q2
$84.2M Sell
743,037
-31,948
-4% -$4.04M 0.83% 22
2024
Q1
$107M Sell
774,985
-18,287
-2% -$2.3M 1% 15
2023
Q4
$98.4M Buy
793,272
+342,075
+76% +$34.9M 0.99% 18
2023
Q3
$42.1M Sell
451,197
-254,773
-36% -$28.7M 0.46% 76
2023
Q2
$90.7M Sell
705,970
-23,682
-3% -$2.86M 0.87% 28
2023
Q1
$84.8M Buy
729,652
+34,592
+5% +$3.87M 0.88% 26
2022
Q4
$78.7M Buy
695,060
+45,110
+7% +$4.95M 0.86% 24
2022
Q3
$52.3M Sell
649,950
-25,643
-4% -$2.17M 0.61% 49
2022
Q2
$50.4M Sell
675,593
-71,783
-10% -$6.55M 0.58% 47
2022
Q1
$95.6M Sell
747,376
-109,352
-13% -$12M 0.87% 24
2021
Q4
$115M Sell
856,728
-189,448
-18% -$27.2M 0.91% 26
2021
Q3
$143M Buy
1,046,176
+265,972
+34% +$33.5M 1.12% 14
2021
Q2
$83.3M Buy
780,204
+114,784
+17% +$11M 0.61% 49
2021
Q1
$59.8M Sell
665,420
-253,596
-28% -$23.8M 0.45% 79
2020
Q4
$84.9M Buy
919,016
+46,480
+5% +$4.15M 0.63% 42
2020
Q3
$89.9M Sell
872,536
-299,076
-26% -$31.2M 0.79% 34
2020
Q2
$119M Sell
1,171,612
-481,512
-29% -$43.1M 1.05% 19
2020
Q1
$111M Sell
1,653,124
-336,724
-17% -$21M 1.25% 11
2019
Q4
$109M Buy
1,989,848
+670,592
+51% +$31.8M 0.8% 36
2019
Q3
$49.2M Sell
1,319,256
-264,256
-17% -$10.3M 0.39% 98
2019
Q2
$59.3M Buy
1,583,512
+324,580
+26% +$10.2M 0.45% 84
2019
Q1
$37.5M Sell
1,258,932
-204,704
-14% -$7.19M 0.27% 144
2018
Q4
$43.8M Sell
1,463,636
-243,620
-14% -$7.73M 0.35% 108
2018
Q3
$61.1M Sell
1,707,256
-943,048
-36% -$29.2M 0.39% 101
2018
Q2
$62.9M Sell
2,650,304
-753,272
-22% -$16M 0.45% 84
2018
Q1
$63.1M Buy
3,403,576
+650,948
+24% +$9.63M 0.46% 84
2017
Q4
$39.5M Sell
2,752,628
-642,052
-19% -$8.35M 0.29% 131
2017
Q3
$41.5M Buy
3,394,680
+1,559,788
+85% +$27.6M 0.3% 135
2017
Q2
$33.6M Sell
1,834,892
-636,200
-26% -$11.8M 0.25% 146
2017
Q1
$52.3M Sell
2,471,092
-859,652
-26% -$16.8M 0.39% 102
2016
Q4
$49.7M Sell
3,330,744
-761,396
-19% -$13.5M 0.38% 100
2016
Q3
$89.7M Sell
4,092,140
-240,492
-6% -$5.35M 0.72% 41
2016
Q2
$85.9M Sell
4,332,632
-424,268
-9% -$7.22M 0.71% 41
2016
Q1
$80.8M Buy
4,756,900
+55,424
+1% +$926K 0.64% 53
2015
Q4
$96.3M Sell
4,701,476
-1,340,812
-22% -$27.9M 0.8% 29
2015
Q3
$130M Sell
6,042,288
-3,587,776
-37% -$80M 1.09% 8
2015
Q2
$193M Buy
9,630,064
+4,199,308
+77% +$73.8M 1.38% 5
2015
Q1
$84.6M Sell
5,430,756
-2,078,620
-28% -$31.4M 0.61% 42
2014
Q4
$103M Sell
7,509,376
-1,156,504
-13% -$14.2M 0.76% 28
2014
Q3
$86.6M Buy
8,665,880
+237,060
+3% +$2.42M 0.7% 35
2014
Q2
$83.6M Sell
8,428,820
-564,696
-6% -$5M 0.62% 46
2014
Q1
$93M Sell
8,993,516
-6,138,696
-41% -$63.5M 0.67% 38
2013
Q4
$134M Sell
15,132,212
-310,840
-2% -$2.46M 0.99% 17
2013
Q3
$109M Buy
15,443,052
+2,031,000
+15% +$12.9M 0.84% 28
2013
Q2
$75.3M Buy
+13,412,052
New +$64.2M 0.63% 45

Other funds holding DXCM

Frontier Capital Management's DXCM Position: Q1 2026 in Review

Frontier Capital Management increased its DexCom (DXCM) stake by 35% in Q1 2026, buying an estimated $9.07M and bringing the position to 505,628 shares worth $31.8M. The position accounts for 0.33% of the portfolio, ranked #120.

Frontier Capital Management first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $193M in Q2 2015. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Frontier Capital Management held 505,628 shares of DexCom worth $31.8M as of Q1 2026.
  • Frontier Capital Management bought 130,297 DexCom shares in Q1 2026, an estimated $9.07M.
  • DexCom made up 0.33% of Frontier Capital Management's portfolio in Q1 2026, its #120 holding.
  • Frontier Capital Management first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
  • Frontier Capital Management's DexCom position peaked at $193M in Q2 2015.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Frontier Capital Management's 13F filing for Q1 2026, filed 15 May 2026.